RSS feed

Publications by Ilvars Silins

19 publications found

Original articles

Lomnytska M, Karlsson E, Jonsdottir B, Lejon AM, Stålberg K, Poromaa IS, Silins I, Graf W (2021)
Peritoneal cancer index predicts severe complications after ovarian cancer surgery
Eur J Surg Oncol, 47 (11), 2915-2924
DOI 10.1016/j.ejso.2021.05.019, PubMed 34053777

Jónsdóttir B, Ripoll MA, Bergman A, Silins I, Poromaa IS, Ahlström H, Stålberg K (2021)
Validation of ¹⁸F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study
Cancer Imaging, 21 (1), 34
DOI 10.1186/s40644-021-00399-2, PubMed 33849649

Jónsdóttir B, Lomnytska M, Poromaa IS, Silins I, Stålberg K (2020)
The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer
Ann Surg Oncol, 28 (1), 244-251
DOI 10.1245/s10434-020-08649-6, PubMed 32472412

Dong HP, Kleinberg L, Silins I, Flørenes VA, Tropé CG, Risberg B, Nesland JM, Davidson B (2008)
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
Cancer, 112 (1), 84-93
DOI 10.1002/cncr.23140, PubMed 17985388

Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA (2007)
Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma
Cancer, 110 (6), 1264-71
DOI 10.1002/cncr.22918, PubMed 17647260

Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007)
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Mol Cancer, 6, 45
DOI 10.1186/1476-4598-6-45, PubMed 17623056

Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007)
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
Cancer, 109 (2), 228-38
DOI 10.1002/cncr.22426, PubMed 17167759

Wu Q, Lind GE, Aasheim HC, Micci F, Silins I, Tropé CG, Nesland JM, Lothe RA, Suo Z (2007)
The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers
Epigenetics, 2 (4), 237-43
DOI 10.4161/epi.2.4.5406, PubMed 18281782

Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R (2006)
Expression of E-cadherin transcriptional regulators in ovarian carcinoma
Virchows Arch, 449 (5), 520-8
DOI 10.1007/s00428-006-0274-6, PubMed 17024425

Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, Davidson B, Risberg B (2006)
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
Am J Clin Pathol, 125 (3), 451-8
DOI 10.1309/15B66DQMFYYM78CJ, PubMed 16613351

Elfgren K, Rylander E, Rådberg T, Strander B, Strand A, Paajanen K, Sjöberg I, Ryd W, Silins I, Dillner J, Swedescreen Study Group (2005)
Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence
Am J Obstet Gynecol, 193 (3 Pt 1), 650-7
DOI 10.1016/j.ajog.2005.01.056, PubMed 16150255

Silins I, Ryd W, Strand A, Wadell G, Törnberg S, Hansson BG, Wang X, Arnheim L, Dahl V, Bremell D, Persson K, Dillner J, Rylander E (2005)
Chlamydia trachomatis infection and persistence of human papillomavirus
Int J Cancer, 116 (1), 110-5
DOI 10.1002/ijc.20970, PubMed 15756673

Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J (2004)
A population-based study of cervical carcinoma and HPV infection in Latvia
Gynecol Oncol, 93 (2), 484-92
DOI 10.1016/j.ygyno.2004.01.044, PubMed 15099967

Silins I, Avall-Lundqvist E, Tadesse A, Jansen KU, Stendahl U, Lenner P, Zumbach K, Pawlita M, Dillner J, Frankendal B (2002)
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients
Gynecol Oncol, 85 (2), 333-8
DOI 10.1006/gyno.2002.6628, PubMed 11972397

Silins I, Tedeschi RM, Kallings I, Dillner J (2002)
Clustering of seropositivities for sexually transmitted infections
Sex Transm Dis, 29 (4), 207-11
DOI 10.1097/00007435-200204000-00004, PubMed 11912461

Silins I, Finnberg N, Ståhl A, Högberg J, Stenius U (2001)
Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat
Carcinogenesis, 22 (12), 2023-31
DOI 10.1093/carcin/22.12.2023, PubMed 11751435

Silins I, Kallings I, Dillner J (2000)
Correlates of the spread of human papillomavirus infection
Cancer Epidemiol Biomarkers Prev, 9 (9), 953-9
PubMed 11008914

Tedeschi R, Caggiari L, Silins I, Kallings I, Andersson-Ellström A, De Paoli P, Dillner J (2000)
Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women
Int J Cancer, 87 (2), 232-5
PubMed 10861480

Silins I, Wang Z, Åvall-Lundqvist E, Frankendal B, Vikmanis U, Sapp M, Schiller JT, Dillner J (1999)
Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis
J Gen Virol, 80 ( Pt 11), 2931-2936
DOI 10.1099/0022-1317-80-11-2931, PubMed 10580926